AICURIS ANTI INFECTIVE CURES GMBH innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	EPO (European Patent Office)	12
#2	United States	9
#3	WIPO (World Intellectual Property Organization)	8
#4	Argentina	7
#5	Canada	7
#6	China	7
#7	Australia	6
#8	Taiwan	6
#9	Uruguay	6
#10	Brazil	4
#11	Hungary	4
#12	Israel	4
#13	Republic of Korea	3
#14	Montenegro	2
#15	Mexico	2
#16	Philippines	2
#17	Serbia	2
#18	Singapore	2
#19	Chile	1
#20	Cuba	1
#21	Dominican Republic	1
#22	EAPO (Eurasian Patent Organization)	1
#23	Japan	1
#24	Republic of Moldova	1
#25	Netherlands	1
#26	Norway	1
#27	New Zealand	1
#28	Ukraine	1

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Heterocyclic compounds
#4	Peptides
#5	Microorganisms
#6	Acyclic or carbocyclic compounds
#7	Unspecified technologies

Publication	Filing date	Title
TW201920163A	2018-07-27	Crystalline form of (2S)-2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-3-[4-[imino[(3R)-3-piperidinylamino]methyl]phenoxy]-propanoic acid
CN110831577A	2018-06-28	Intravaginal administration device containing antiviral compounds
WO2018065636A1	2017-12-21	COMBINATION THERAPY WITH AMIDINE SUBSTITUTED ß-LACTAM COMPOUNDS AND ß-LACTAMASE INHIBITORS FOR INFECTIONS WITH ANTIBIOTIC RESISTANT BACTERIAL STRAINS
WO2018095576A1	2017-11-28	Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide
CN109982696A	2017-11-17	The amidine for treating bacterium infection replaces the Liposomal formulation of 'beta '-lactam compounds
CN110022857A	2017-11-17	Based on the amidine of modified cyclodextrin and acidulant replace 'beta '-lactam compounds novel formulation, its preparation and as antimicrobial pharmceutical compositions purposes
EP3474887A1	2017-06-27	Hcmv entry inhibitors